Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
The Canadian Journal of Urology
|
March 1, 2016
Gender differences in overactive bladder
Renu S Eapen, Sidney B Radomski
Research and Reports in Urology
|
June 29, 2016
Review of the epidemiology of overactive bladder
Renu S Eapen, Sidney B Radomski
Current Opinion in Urology
|
December 4, 2024
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects
Chris Ho-Ming Wong, Rossella Nicoletti, Elio Mazzone, et al.
The Urologic Clinics of North America
|
November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier
Annika Herlemann, Samuel L Washington, Renu S Eapen, et al.
Current Opinion in Urology
|
February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging
Renu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Current Opinion in Urology
|
July 22, 2025
VISION, TheraP, LuTectomy and beyond - is there a role for lutetium therapy in biochemical recurrence?
David Hennes, Jasmin Weindler, Christa Babst, et al.
European Urology Focus
|
December 7, 2025
Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions
Abdullah Al-Khanaty, David Hennes, Marlon L Perera, et al.
Seminars in Nuclear Medicine
|
July 3, 2023
Role of FDG PET/CT in Management of Patients with Prostate Cancer
Duncan E K Sutherland, Arun A Azad, Declan G Murphy, et al.
Prostate Cancer and Prostatic Diseases
|
September 2, 2018
Practice patterns of primary EBRT with and without ADT in prostate cancer treatment
Bogdana Schmidt, Renu S Eapen, Janet E Cowan, et al.
Cancers
|
January 10, 2026
Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future Directions
Kieran Sandhu, Abdullah Al-Khanaty, David Hennes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
The Canadian Journal of Urology
|
March 1, 2016
Gender differences in overactive bladder
Renu S Eapen, Sidney B Radomski
Research and Reports in Urology
|
June 29, 2016
Review of the epidemiology of overactive bladder
Renu S Eapen, Sidney B Radomski
Current Opinion in Urology
|
December 4, 2024
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects
Chris Ho-Ming Wong, Rossella Nicoletti, Elio Mazzone, et al.
The Urologic Clinics of North America
|
November 7, 2017
Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier
Annika Herlemann, Samuel L Washington, Renu S Eapen, et al.
Current Opinion in Urology
|
February 22, 2017
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging
Renu S Eapen, Annika Herlemann, Samuel L Washington, et al.
Current Opinion in Urology
|
July 22, 2025
VISION, TheraP, LuTectomy and beyond - is there a role for lutetium therapy in biochemical recurrence?
David Hennes, Jasmin Weindler, Christa Babst, et al.
European Urology Focus
|
December 7, 2025
Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future Directions
Abdullah Al-Khanaty, David Hennes, Marlon L Perera, et al.
Seminars in Nuclear Medicine
|
July 3, 2023
Role of FDG PET/CT in Management of Patients with Prostate Cancer
Duncan E K Sutherland, Arun A Azad, Declan G Murphy, et al.
Prostate Cancer and Prostatic Diseases
|
September 2, 2018
Practice patterns of primary EBRT with and without ADT in prostate cancer treatment
Bogdana Schmidt, Renu S Eapen, Janet E Cowan, et al.
Cancers
|
January 10, 2026
Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future Directions
Kieran Sandhu, Abdullah Al-Khanaty, David Hennes, et al.
Page
of 2